{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:11:17Z","timestamp":1791213077954,"version":"4.1.0"},"reference-count":41,"publisher":"American Association for Cancer Research (AACR)","issue":"1","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Mutation in the von Hippel-Lindau (VHL) protein associated with renal cell carcinoma causes hypoxia-inducible factor (HIF) to stabilize and consequently to induce various HIF-targeting proteins. In this study, we found that proopiomelanocortin (POMC), an adrenocorticotropic hormone precursor, is up-regulated constitutively in VHL-mutated renal cell carcinoma. A critical transcription factor responsible for POMC overproduction was identified as Nur77, a member of the orphan steroid receptor superfamily. Little is known about how VHL mutation leads to activation of Nur77. We report that Nur77 is directly regulated by HIF. We show that HIF-1\u03b1, but not HIF-2\u03b1, binds to a putative HIF responsive element in the Nur77 promoter, activating the expression of Nur77. Mutation or deletion of the HIF binding site in the Nur77 promoter abrogates activation of a luciferase reporter gene under the control of Nur77 promoter by HIF-1\u03b1. The treatment of Nur77 antisense oligonucleotide reduces POMC transcription under hypoxic conditions. We confirmed that Nur77 and POMC are up-regulated in VHL-mutated renal cell carcinoma. In this study, we provide the first molecular evidence that Nur77 activated by HIF under hypoxic conditions regulates production of the peptide hormone precursor POMC.<\/jats:p>","DOI":"10.1158\/0008-5472.can-03-0145","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T22:35:47Z","timestamp":1127255747000},"page":"35-39","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Nur77 Activated by Hypoxia-Inducible Factor-1\u03b1 Overproduces Proopiomelanocortin in von Hippel-Lindau-Mutated Renal Cell Carcinoma"],"prefix":"10.1158","volume":"64","author":[{"given":"Ji-Woong","family":"Choi","sequence":"first","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, Cancer Research Institute, Seoul, South Korea; 2The Aging and Apoptosis Research Center, Seoul, South Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Chul","family":"Park","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, Cancer Research Institute, Seoul, South Korea; 2The Aging and Apoptosis Research Center, Seoul, South Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeong Hoon","family":"Kang","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun O.","family":"Liu","sequence":"additional","affiliation":[{"name":"4Department of Pharmacology and Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Duk","family":"Youn","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and Molecular Biology, Cancer Research Institute, Seoul, South Korea; 2The Aging and Apoptosis Research Center, Seoul, South Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2004,1,16]]},"reference":[{"key":"2022061620091088300_B1","doi-asserted-by":"crossref","unstructured":"Semenza G. L. HIF-1, O2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus.. Cell, 107:\u20081-3, \u20082001.","DOI":"10.1016\/S0092-8674(01)00518-9"},{"key":"2022061620091088300_B2","doi-asserted-by":"crossref","unstructured":"Wenger R. H. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression.. FASEB J., 16:\u20081151-1162, \u20082002.","DOI":"10.1096\/fj.01-0944rev"},{"key":"2022061620091088300_B3","doi-asserted-by":"crossref","unstructured":"Tian H., McKnight S. L., Russell D. W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev., 11:\u200872-82, \u20081997.","DOI":"10.1101\/gad.11.1.72"},{"key":"2022061620091088300_B4","doi-asserted-by":"crossref","unstructured":"Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y., Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarly to hypoxia-inducible factor 1\u03b1 regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. USA, 94:\u20084273-4278, \u20081997.","DOI":"10.1073\/pnas.94.9.4273"},{"key":"2022061620091088300_B5","doi-asserted-by":"crossref","unstructured":"Flamme I., Frohlich T., von Reutern M., Kappel A., Damert A., Risau W. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1\u03b1 and developmentally expressed in blood vessels. Mech. Dev., 63:\u200851-60, \u20081997.","DOI":"10.1016\/S0925-4773(97)00674-6"},{"key":"2022061620091088300_B6","doi-asserted-by":"crossref","unstructured":"Hogenesch J. B., Chan W. K., Jackiw V. H., Brown R. C., Gu Y-Z., Pray-Grant M., Perdew G. H., Bradfield C. A. Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J. Biol. Chem., 272:\u20088581-8593, \u20081997.","DOI":"10.1074\/jbc.272.13.8581"},{"key":"2022061620091088300_B7","doi-asserted-by":"crossref","unstructured":"O\u2019Rourke J. F., Tian Y. M., Ratcliffe P. J., Pugh C. W. Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor-1\u03b1.. J. Biol. Chem., 274:\u20082060-2071, \u20081999.","DOI":"10.1074\/jbc.274.4.2060"},{"key":"2022061620091088300_B8","doi-asserted-by":"crossref","unstructured":"Maxwell P. H., Wiesener M. S., Chang G. W., Clifford S. C., Vaux E. C., Cockman M. E., Wykoff C. C., Pugh C. W., Maher E. R., Ratcliffe P. J. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (Lond.), 399:\u2008271-275, \u20081999.","DOI":"10.1038\/20459"},{"key":"2022061620091088300_B9","doi-asserted-by":"crossref","unstructured":"Mahon P. C., Hirota K., Semenza G. L. FIH-1: a novel protein that interacts with HIF-1\u03b1 and VHL to mediate repression of HIF-1 transcriptional activity.. Genes Dev., 15:\u20082675-2686, \u20082001.","DOI":"10.1101\/gad.924501"},{"key":"2022061620091088300_B10","doi-asserted-by":"crossref","unstructured":"Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J. M., Lane W. S., Kaelin W. G., Jr. HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.. Science (Wash. D C), 292:\u2008464-468, \u20082001.","DOI":"10.1126\/science.1059817"},{"key":"2022061620091088300_B11","doi-asserted-by":"crossref","unstructured":"Jaakkola P., Mole D. R., Tian Y. M., Wilson M. I., Gielbert J., Gaskell S. J., Kriegsheim A. A., Hebestreit H. F., Mukherji M., Schofield C. J., Maxwell P. H., Pugh C. W., Ratcliffe P. J. Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science (Wash. D C), 292:\u2008468-472, \u20082001.","DOI":"10.1126\/science.1059796"},{"key":"2022061620091088300_B12","doi-asserted-by":"crossref","unstructured":"Epstein A. C., Gleadle J. M., McNeill L. A., Hewitson K. S., O\u2019Rourke J., Mole D. R., Mukherji M., Metzen E., Wilson M. I., Dhanda A., Tian Y. M., Masson N., Hamilton D. L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P. H., Pugh C. W., Schofield C. J., Ratcliffe P. J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell, 107:\u200843-54, \u20082001.","DOI":"10.1016\/S0092-8674(01)00507-4"},{"key":"2022061620091088300_B13","doi-asserted-by":"crossref","unstructured":"Bruick R. K., McKnight S. L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science (Wash. D C), 294:\u20081337-1340, \u20082001.","DOI":"10.1126\/science.1066373"},{"key":"2022061620091088300_B14","doi-asserted-by":"crossref","unstructured":"Semenza G. L. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology.. Trends Mol. Med., 7:\u2008345-350, \u20082001.","DOI":"10.1016\/S1471-4914(01)02090-1"},{"key":"2022061620091088300_B15","unstructured":"Cotran R. S., Kumar V., Robbins S. L. The kidney   Cotran R. S. Kumar V. Robbins S. L. eds. . Pathologic Basis of Disease, Chapter 20,  5th ed. 985-988,   W. B. Saunders Philadelphia   \u20081994."},{"key":"2022061620091088300_B16","doi-asserted-by":"crossref","unstructured":"Orth D. N. Cushing\u2019s syndrome. N. Engl. J. Med., 332:\u2008791-803, \u20081995.","DOI":"10.1056\/NEJM199503233321207"},{"key":"2022061620091088300_B17","doi-asserted-by":"crossref","unstructured":"Stuart S., Chandran P. K. G. Oncogenic Cushing\u2019s syndrome and nephritic syndrome in the same patient. Am. J. Kid. Dis., 37:\u20081-4, \u20082001.","DOI":"10.1016\/S0272-6386(01)90014-9"},{"key":"2022061620091088300_B18","doi-asserted-by":"crossref","unstructured":"Philips A., Lesage S., Gingras R., Maira M-H., Gauthier Y., Hugo P., Drouin J. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol. Cell. Biol., 17:\u20085946-5951, \u20081997.","DOI":"10.1128\/MCB.17.10.5946"},{"key":"2022061620091088300_B19","doi-asserted-by":"crossref","unstructured":"Ray D. W., Ren S-G., Melmed S. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph line: role of STAT pathway.. J. Clin. Investig., 97:\u20081852-1859, \u20081996.","DOI":"10.1172\/JCI118615"},{"key":"2022061620091088300_B20","doi-asserted-by":"crossref","unstructured":"Murphy E. P., Conneely O. M. Neuronendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1\/nur77 subfamily of nuclear receptors. Mol. Endocrinol., 16:\u200839-47, \u20081997.","DOI":"10.1210\/mend.11.1.9874"},{"key":"2022061620091088300_B21","doi-asserted-by":"crossref","unstructured":"Ueda Y., Bandoh S., Fujita J., Sato M., Yamaji Y., Takahara J. Expression of nerve growth factor-induced clone B subfamily and pro-opiomelanocortin gene in lung cancer cell lines. Am. J. Respir. Cell Mol. Biol., 20:\u20081319-1325, \u20081999.","DOI":"10.1165\/ajrcmb.20.6.3577"},{"key":"2022061620091088300_B22","doi-asserted-by":"crossref","unstructured":"Paez-Pereda M., Kovalovsky D., Hopfner U., Theodoropoulou M., Pagotto U., Uhl E., Losa M., Stalla J., Grubler Y., Missale C., Artz E., Stalla G. K. Retinoic acid prevents experimental Cushing syndrome. J. Clin. Investig., 108:\u20081123-1131, \u20082001.","DOI":"10.1172\/JCI11098"},{"key":"2022061620091088300_B23","doi-asserted-by":"crossref","unstructured":"Cockman M. E., Masson N., Mole D. R., Jaakkola P., Chang G-W., Clifford S. C., Maher E. R., Pugh C. W., Ratcliffe P. J., Maxwell P. H. Hypoxia inducible factor-\u03b1 binding and ubiquitination by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem., 275:\u200825733-25741, \u20082000.","DOI":"10.1074\/jbc.M002740200"},{"key":"2022061620091088300_B24","doi-asserted-by":"crossref","unstructured":"Rees B. B., Bowman J. A. L., Schulte P. M. Structure and sequence conservation of a putative response element in the lactate dehydrogenase-B gene of Fundulus.. Biol. Bull., 200:\u2008247-251, \u20082001.","DOI":"10.2307\/1543505"},{"key":"2022061620091088300_B25","doi-asserted-by":"crossref","unstructured":"Ebert B. L., Bunn H. F. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300\/CREB binding proteins. Mol. Cell Biol., 18:\u20084089-4096, \u20081998.","DOI":"10.1128\/MCB.18.7.4089"},{"key":"2022061620091088300_B26","doi-asserted-by":"crossref","unstructured":"Braems G. A., Matthews S. G., Challis J. R. Differential regulation of proopiomelanocortin messenger ribonucleic acid in the pars distalis and pars intermedia of the pituitary gland after prolonged hypoemia in fetal sheep. Endocrinology, 137:\u20082731-2738, \u20081996.","DOI":"10.1210\/endo.137.7.8770892"},{"key":"2022061620091088300_B27","doi-asserted-by":"crossref","unstructured":"Fraser M., Braems G. A., Challis J. R. Developmental regulation of corticotrophin receptor gene expression in the adrenal gland if the ovine fetus and newborn lamb: effects of hypoxia during late pregnancy.. J. Endocrinol., 169:\u20081-10, \u20082001.","DOI":"10.1677\/joe.0.1690001"},{"key":"2022061620091088300_B28","doi-asserted-by":"crossref","unstructured":"Stocco C. O., Lau L. F., Gibori G. A calcium\/calmodulin-dependent activation of ERK1\/2 mediates JunD phosphorylation and induction of nur77 and 20\u03b1-hsd genes by prostaglandin F2\u03b1 in ovarian cells. J. Biol. Chem., 277:\u20083293-3302, \u20082002.","DOI":"10.1074\/jbc.M110936200"},{"key":"2022061620091088300_B29","doi-asserted-by":"crossref","unstructured":"Crawford P. A., Sadovsky Y., Woodson K., Lee S. L., Milbrandt J. Adrenocortical function and regulation of the steroid 21-hydroxylase gene in NGFI-B-deficient mice. Mol. Cell. Biol., 15:\u20084331-4336, \u20081995.","DOI":"10.1128\/MCB.15.8.4331"},{"key":"2022061620091088300_B30","doi-asserted-by":"crossref","unstructured":"Philips A., Maira M., Mullick S., Chamberland P., Lesage S., Hugo P., Drouin J. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol. Cell. Biol., 17:\u20085952-5959, \u20081997.","DOI":"10.1128\/MCB.17.10.5952"},{"key":"2022061620091088300_B31","doi-asserted-by":"crossref","unstructured":"Winoto A., Littman D. R. Nuclear hormone receptors in T lymphocytes. Cell, 109:\u2008S57-S66, \u20082002.","DOI":"10.1016\/S0092-8674(02)00710-9"},{"key":"2022061620091088300_B32","doi-asserted-by":"crossref","unstructured":"Youn H-D., Sun L., Prywes R., Liu J. O. Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science (Wash. D C), 286:\u2008790-793, \u20081999.","DOI":"10.1126\/science.286.5440.790"},{"key":"2022061620091088300_B33","doi-asserted-by":"crossref","unstructured":"Youn H-D., Liu J. O. Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity, 13:\u200885-94, \u20082000.","DOI":"10.1016\/S1074-7613(00)00010-8"},{"key":"2022061620091088300_B34","doi-asserted-by":"crossref","unstructured":"Yoon J. K., Lau L. F. Involvement of JunD in transcriptional activation of the orphan receptor gene nur77 by nerve growth factor and membrane depolarization in PC12 cells. Mol. Cell. Biol., 14:\u20087731-7743, \u20081994.","DOI":"10.1128\/mcb.14.12.7731-7743.1994"},{"key":"2022061620091088300_B35","doi-asserted-by":"crossref","unstructured":"Liu X., Chen X., Zachar V., Chang C., Ebbesen P. Transcriptional activation of human TR3\/nur77 gene expression by human T-lymphotrophic virus type I Tax protein through two AP-1-like elements. J. Gen. Virol., 80:\u20083073-3081, \u20081999.","DOI":"10.1099\/0022-1317-80-12-3073"},{"key":"2022061620091088300_B36","doi-asserted-by":"crossref","unstructured":"Brusselmans K., Bono F., Maxwell P., Dor Y., Dewerchin M., Collen D., Herbert J. M., Carmeliet P. Hypoxia-inducible factor-2\u03b1 (HIF-2\u03b1) is involved in the apoptotic response to hypoglycemia but not to hypoxia. J. Biol. Chem., 276:\u200839192-39196, \u20082001.","DOI":"10.1074\/jbc.C100428200"},{"key":"2022061620091088300_B37","doi-asserted-by":"crossref","unstructured":"Lando D., Pongratz I., Poellinger L., Whitelaw M. L. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1\u03b1 and the HIF-like factor. J. Biol. Chem., 275:\u20084618-4627, \u20082000.","DOI":"10.1074\/jbc.275.7.4618"},{"key":"2022061620091088300_B38","doi-asserted-by":"crossref","unstructured":"Ryan H. E., Lo J., Johnson R. S. HIF-1\u03b1 is required for solid tumor formation and embryonic vascularization. EMBO J., 17:\u20083005-3015, \u20081998.","DOI":"10.1093\/emboj\/17.11.3005"},{"key":"2022061620091088300_B39","doi-asserted-by":"crossref","unstructured":"Iyer N. V., Kotch L. E., Agani F., Leung S. W., Laughner E., Wenger R. H., Gassman M., Gearhart J. D., Lawler A. M., Yu A. Y., Semenza G. L. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1\u03b1. Genes Dev., 12:\u2008149-162, \u20081998.","DOI":"10.1101\/gad.12.2.149"},{"key":"2022061620091088300_B40","doi-asserted-by":"crossref","unstructured":"Tian H., Hammer R. E., Matsumoto A. M., Russell D. W., McKnight S. L. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev., 12:\u20083320-3324, \u20081998.","DOI":"10.1101\/gad.12.21.3320"},{"key":"2022061620091088300_B41","doi-asserted-by":"crossref","unstructured":"Peng J., Zhang L., Drysdale L., Fong G. H. The transcription factor EPAS-1\/hypoxia-inducible factor 2\u03b1 plays an important role in vascular remodeling. Proc. Natl. Acad. Sci. USA, 97:\u20088386-8391, \u20082000.","DOI":"10.1073\/pnas.140087397"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/1\/35\/2514125\/zch00104000035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/1\/35\/2514125\/zch00104000035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T20:10:32Z","timestamp":1655410232000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/64\/1\/35\/511229\/Nur77-Activated-by-Hypoxia-Inducible-Factor-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,1,16]]},"published-print":{"date-parts":[[2004,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-03-0145","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,1]]}}}